New radiation strategy tested for childhood brain cancer
NCT ID NCT01351870
First seen Sep 30, 2025 · Last updated May 19, 2026 · Updated 34 times
Summary
This study tested whether giving radiation in many small doses (hyperfractionated) works better than the usual schedule for children and teens with standard-risk medulloblastoma, a type of brain tumor. The trial included 52 participants aged 4 to 21. The goal was to see if the new approach improves how long the cancer stays away without increasing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDULLOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.